US Stock MarketDetailed Quotes

IRWD Ironwood Pharmaceuticals

Watchlist
  • 6.720
  • +0.090+1.36%
Close Jul 19 16:00 ET
  • 6.970
  • +0.250+3.72%
Post 19:51 ET
1.07BMarket Cap-998P/E (TTM)

Ironwood Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ironwood Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

74.88M

-28.05%
EPS(YoY)

-0.03

-112.00%
Analyst Rating

Strong Buy

Jul 21, 2024

Ironwood Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 110.167M--
--2024/Q2-- / 107.000M--
May 9, 20242024/Q174.877M / 105.750M--
Feb 15, 20242023/Q4117.553M / 117.400M--
Nov 9, 20232023/Q3113.739M / 112.816M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 110.167M--
--2024/Q2-- / 107.000M--
May 9, 20242024/Q174.877M / 105.750M--
Feb 15, 20242023/Q4117.553M / 117.400M--
Nov 9, 20232023/Q3113.739M / 112.816M--

Unlock Free Earnings Estimates

Ironwood Pharmaceuticals Earnings Reports

  • Ironwood Pharmaceuticals | 10-Q: Quarterly report

    May 9 16:51 ET

  • Ironwood Pharmaceuticals | 10-K: Annual report

    Feb 16 07:06 ET

  • Ironwood Pharmaceuticals: Q3 2023 Earnings Report

    Nov 9, 2023 16:18 ET

  • Ironwood Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 9, 2023 16:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 21, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg